SNAP-8
Acetyl Octapeptide-3 · Anti-Wrinkle & Expression Line Peptide
Synthetic octapeptide functioning as topical Botox alternative, targeting dynamic facial wrinkles through SNARE complex modulation. Up to 63% wrinkle depth reduction demonstrated clinically.
Overview
Synthetic octapeptide functioning as topical Botox alternative, targeting dynamic facial wrinkles through SNARE complex modulation. Up to 63% wrinkle depth reduction demonstrated clinically.
Mimics SNAP-25 protein N-terminal, competitively inhibits SNARE complex formation, reduces acetylcholine release at neuromuscular junctions.
Research indications
What the compound has been studied for, grouped by body system. Effect size is the reported magnitude where it was measured — not a recommendation.
Demonstrates up to 63% reduction in wrinkle depth around eyes/forehead over 28 days.
Targets horizontal lines from repetitive eyebrow-raising and facial expressions.
Reduces periorbital wrinkles via localized muscle relaxation without affecting natural expressions.
43% inhibition efficiency at therapeutic concentrations.
Localized relaxation at application sites without systemic effects.
Slows new expression line formation before becoming static wrinkles.
A large effect in a weak study and a small effect in a strong one are different things. Effect size is never evidence of use in people.
- Class
- Acetylated octapeptide
- Chain length
- 8 residues
- Molecular weight
- 1075.16 Da
- Typical dose
- 3-10% topical concentration (0.33-1mg injectable)
- Frequency
- 2x daily for topical (morning and evening)
- Cycle length
- Continuous use for maintained results
- Storage
- Topical: 4-25°C. Reconstituted injectable: 2-8°C, use within 30 days
Molecular data
- Type
- Acetylated octapeptide
- Molecular weight
- 1075.16 Da
- Chain length
- 8 residues
Dosing reference
Doses reported in the literature and by suppliers. These are a record of what has been used in research — reference, never instruction.
| Context | Route | Amount | Frequency |
|---|---|---|---|
| General Anti-Aging | Serum/cream | 3-5% concentration | 2x daily |
| Intensive Wrinkle Treatment | Targeted application | 5-10% concentration | 2x daily |
| Eye Area Treatment | Eye cream/serum | 3-5% concentration | 2x daily |
| Preventive Use | Daily moisturizer | 3% concentration | 1-2x daily |
| Initial Phase (Weeks 1-4) | SubQ | 0.33mg (330mcg) | 1x daily |
| Mid-Phase (Weeks 5-8) | SubQ | 0.5mg (500mcg) | 1x daily |
| Target Phase (Weeks 9-12) | SubQ | 1.0mg (1000mcg) | 1x daily |
Interactions
Parent compound with same mechanism; SNAP-8 ~30% more potent; may be redundant when combined.
Research shows 47% total inhibition combined vs 38% and 7% independently.
Complementary mechanisms—SNAP-8 reduces expression lines; GHK-Cu promotes collagen synthesis.
Excellent combination; hydration and plumping effects enhance wrinkle reduction.
Safe together; niacinamide calms barrier while SNAP-8 targets expression lines.
Both potent actives; introduce slowly or use separately (SNAP-8 morning, retinol evening).
pH differences may affect stability; use Vitamin C morning, SNAP-8 evening.
Acids destabilize peptides; use at different times—acids morning, peptides evening.
Complementary anti-aging—Matrixyl stimulates collagen; SNAP-8 relaxes muscles.
Quality checklist
- ✓Clear, colorless to slightly yellowish solution with no visible particles
- ✓pH between 3.0-5.0 for stability and skin compatibility
- ✓Airless pump, dark glass, or UV-protected packaging
- ✓Subtle, measurable wrinkle reduction over 2-4 weeks
- !Many commercial products contain subtherapeutic concentrations; verify 3-10% SNAP-8
- ×Cloudy or discolored solution—indicates degradation or contamination
- ×Strong odor or unusual smell—suggests contamination or degradation
What to expect
Safety
- Mild irritation or redness (especially at 5-10% concentrations initially)
- Minimal risk on sensitive periorbital areas
- Persistent skin irritation, burning, or redness unresolved within days
- Allergic reaction (rash, hives, swelling, difficulty breathing)
- Unusual skin discoloration in treated areas
- Worsening skin condition after 2+ weeks of use
- Eye irritation or vision changes if product enters eyes
- Pregnancy and breastfeeding (insufficient safety data)
- Known peptide allergies
FAQ
How does SNAP-8 compare to Botox in terms of wrinkle reduction?
SNAP-8 achieves up to 63% wrinkle depth reduction topically, while Botox is ~95%+ for injection. Botox works faster (3-7 days) and lasts longer (3-4 months). SNAP-8 takes 4-6 weeks and effects fade in 2-4 weeks post-discontinuation. SNAP-8 is a non-invasive alternative with results closer to strong topicals than true Botox equivalence.
Can SNAP-8 damage my facial expressions, or does it let me maintain normal movement?
SNAP-8 maintains natural expressions. It reduces acetylcholine release (like Botox) but topically at the application site, not systemically via injection. The mechanism is the same, but localized application means you keep movement control. Your expressions will be slightly relaxed where applied, but not frozen like heavy Botox use.
Should I use 3% or 10% SNAP-8 concentration for faster results?
Higher concentrations (5-10%) work faster and more aggressively but increase irritation risk. Start with 3-5% and assess tolerance. You can upgrade after 2-3 weeks if you're tolerating it well. The file warns that many commercial products contain subtherapeutic concentrations, so verify actual SNAP-8 content before purchasing.
Can I use SNAP-8 year-round, or should I cycle it?
Topical SNAP-8 can be used continuously for maintained results. Effects fade in 2-4 weeks after discontinuation, so ongoing use is needed. Unlike injectable peptides, there's no accumulation risk or GABAergic desensitization with topical application. You can use it indefinitely as part of your skincare routine.
References
- 1A Synthetic Hexapeptide (Argireline) with Antiwrinkle ActivityBlanes-Mira C, Clemente J, Jodas G, et al. · International Journal of Cosmetic Science · 2002
10% argireline emulsion reduced wrinkle depth up to 30% in 30 days. Mechanism: competitive inhibition of SNARE complex formation with potency similar to BoNT-A but non-toxic.
reviewPubMed 18498523 ↗ - 2The Anti-Wrinkle Efficacy of Argireline, a Synthetic Hexapeptide, in Chinese Subjects: A Randomized, Placebo-Controlled StudyWang Y, Wang M, Xiao S, et al. · American Journal of Clinical Dermatology · 2013
60 subjects randomized 3:1 argireline vs placebo. Total anti-wrinkle efficacy 48.9% argireline vs 0% placebo (P<0.01). Roughness parameters significantly decreased. First multicenter RCT of the parent compound.
human-rctPubMed 23417317 ↗ - 3Cosmeceutical Peptides in the Framework of Sustainable Wellness EconomyKatayama S, et al. · International Journal of Molecular Sciences · 2020
SNAP-8 demonstrated 43% SNARE complex inhibition at therapeutic concentrations. Synergistic with Leuphasyl: 47% total inhibition combined vs 38% and 7% independently.
reviewPubMed 33195061 ↗ - 4Clinical Safety and Efficacy Evaluation of a Dissolving Microneedle Patch Having Dual Anti-Wrinkle EffectsKim JH, et al. · Annals of Dermatology · 2024
24 subjects evaluated dissolving microneedle patch with acetyl octapeptide-3 (SNAP-8). Enhanced wrinkle reduction vs topical alone, improved skin elasticity and lifting with no adverse effects over 28 days.
reviewPubMed 39082657 ↗